Skip to main content

Medtronic takes 'first step' toward U.S. sale of artificial pancreas

Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe.

The long-awaited results of the clinical trial may pave the way for U.S. approval of the device, made by Medtronic, which already sells insulin pumps with an automatic shutoff feature in 50 countries outside the United States. The feature is meant to guard against delivering insulin to diabetics their blood sugar is already too low.

 

As many as 3 million Americans have type 1 diabetes, in which the immune system destroys cells in the pancreas that make insulin.

Type 1 diabetes must monitor their blood sugar and take insulin several times a day. Too little insulin can cause high blood sugar, increasing the risk of long-term complications such as eye damage, kidney failure and heart disease. But too much insulin can cause blood sugar to drop too low, causing hypoglycemia, which can result in seizures, unconsciousness, brain damage and death.

U.S. regulators have refused to allow insulin pumps with an automatic shutoff feature on the U.S. market without a large, carefully controlled clinical trial proving they are safe.

The latest study, known as ASPIRE, which tested the system in 247 people with diabetes in their homes, offered the proof.

It showed the device reduced the amount of time and the duration that a diabetic's blood sugar fell below a certain threshold - a measure known as area under the curve - by 37.5 percent. The device reduced the overall number of low blood sugar episodes by 31.8 percent compared to diabetics using an insulin pump without the shutoff feature.

The findings were published online on Saturday in the New England Journal of Medicine and presented at the American Diabetes Association meeting in Chicago.

Dr. Francine Kaufman, vice president of global medical affairs for Medtronic's diabetes business, said the study showed that shutting off the flow of insulin mimics what happens in healthy people in response to low blood sugar.

Kaufman, a pediatric endocrinologist who still has an active practice in Los Angeles, said the device is intended to help diabetics who may find themselves in a situation where they cannot help themselves.

"Many of my patients are 3 years old. So, if mom is not around, they don't know how to do this on their own," she said. "We're going to take that and automate it for them."

Dr Richard Bergenstal, of the International Diabetes Center at Park Nicollet Health Services in Minneapolis, the study's lead author, highlighted the study's findings.

"That is a significant reduction in the duration and severity of low blood sugar," he told a news briefing at the diabetes meeting.

'HOLY GRAIL'

Diabetes advocates, researchers and medical device companies for decades have spoken wistfully about the "holy grail" of an artificial pancreas, a complex system of pumps and sensors aimed at automating the complex care and treatment of type 1 diabetes by mimicking the function of a real pancreas.

The Medtronic device is decidedly not that. But it is the first device before the U.S. Food and Drug Administration to detect dangerous blood sugar levels and automatically take action to correct it.

_0">

"The study results are important as we continue to move toward our goal of developing a fully automated system, or artificial pancreas, that will one day require very minimal interaction from the patient," Medtronic's Kaufman said.

_1">

In designing the study, researchers had to find a population of patients who were especially prone to having hypoglycemia at night. Bergenstal said as many as 320 people tried to enroll in the study, but only 247 qualified.

_2">

'THEY DIDN'T WAKE UP'

_3">

Spears Mallis, a 34-year-old administrator for the Longstreet Cancer Center in Gainesville, Georgia, was one.

_4">

Mallis, an avid runner, has had type 1 diabetes for almost 17 years. For the past 16 or so, he has used an insulin pump, often pared with a continuous glucose monitor, to keep track of his blood sugar and deliver a steady flow of insulin.

_5">

But Mallis still suffers from occasional bouts of hypoglycemia, which were especially disturbing when he had a job that required him to travel.

_6">

Like many in the diabetes community, Mallis was aware of efforts several years ago by the Juvenile Diabetes Research Foundation and others to push the FDA to set guidelines for approving the Medtronic device. Some had even hoped the agency would allow these devices on the U.S. market without additional testing. But in 2011, the FDA made clear the company would need a clinical trial, and Mallis was on board.

_7">

During the three-month trial, Mallis said the suspend device kicked in several times. "In one of my races, it went off and I had it go straight to suspend."

_8">

He said the device's alarm feature was loud enough to wake his wife, but there were times he would sleep through it. "After you have type 1 diabetes for awhile, your senses become lessened for feeling low blood sugar."

_9">

Mallis said the device would stop the flow of insulin until he woke and took action himself.

_10">

His experience was typical. Bergenstal said for many individuals, the device was suspended for the full two-hour maximum, despite the alarm. "They didn't wake up."

_11">

The study was also designed to see if cutting off insulin for this period would cause insulin to "rocket back up," Bergenstal said. But at the end of the two-hour period, it just "gradually drifted back up into the normal range," he said.

_12">

The study also showed the device had no impact on a measure of long-term control of blood sugar called A1c.

_13">

Kaufman said Medtronic has presented the study results to the FDA and received an approvable letter for its next-generation pump device that includes the feature, meaning the device can be approved provided the company meets certain conditions. Chief Executive Omar Ishrak has said he expects device approval during the current calendar year.

_14">

"We are just going back and forth on overall quality issues. We're working very collaboratively with FDA to work through some of the issues," Kaufman said.

_15">

Meanwhile, the company and its rivals, including Johnson & Johnson's Animas unit, are working on next-generation devices that add more automated features.

_0">

On Friday, the company presented results at the diabetes meeting on a study of a system designed to predict when diabetics are heading for a dangerous low and take preemptive action by decreasing the amount of insulin the pump delivers.

_1">

The night-time study of 20 adults with type 1 diabetes showed the software control program helped people stay within a target range for 90 percent of the time.

_2">

Ramakrishna Venugopalan, director for research and development at Animas, sees the development of an artificial pancreas as a step-wise process, in which products begin to automate more and more of the functions now managed by patients.

_3">

The company this month won approval for another feasibility study, its third in three years.

_4">

Venugopalan still can't say when a fully automated artificial pancreas will be available, but adds, "I don't think this is a pipe dream."

_5">

(Reporting by Julie Steenhuysen; Editing by Michele Gershberg and Leslie Adler)

_6">

Popular posts from this blog

Study Abroad USA, College of Charleston, Popular Courses, Alumni

Thinking for Study Abroad USA. School of Charleston, the wonderful grounds is situated in the actual middle of a verifiable city - Charleston. Get snatched up by the wonderful and customary engineering, beautiful pathways, or look at the advanced steel and glass building which houses the School of Business. The grounds additionally gives students simple admittance to a few major tech organizations like Amazon's CreateSpace, Google, TwitPic, and so on. The school offers students nearby as well as off-grounds convenience going from completely outfitted home lobbies to memorable homes. It is prepared to offer different types of assistance and facilities like clubs, associations, sporting exercises, support administrations, etc. To put it plainly, the school grounds is rising with energy and there will never be a dull second for students at the College of Charleston. Concentrate on Abroad USA is improving and remunerating for your future. The energetic grounds likewise houses various

Best MBA Online Colleges in the USA

“Opportunities never open, instead we create them for us”. Beginning with this amazing saying, let’s unbox today’s knowledge. Love Business and marketing? Want to make a high-paid career in business administration? Well, if yes, then mate, we have got you something amazing to do!   We all imagine an effortless future with a cozy house and a laptop. Well, well! You can make this happen. Today, with this guide, we will be exploring some of the top-notch online MBA universities and institutes in the USA. Let’s get started! Why learn Online MBA from the USA? Access to More Options This online era has given a second chance to children who want to reflect on their careers while managing their hectic schedules. In this, the internet has played a very crucial in rejuvenating schools, institutes, and colleges to give the best education to students across the globe. Graduating with Less Debt Regular classes from high reputed institutes often charge heavy tuition fees. However onl

Sickening moment maskless 'Karen' COUGHS in the face of grocery store customer, then claims she doesn't have to wear a mask because she 'isn't sick'

A woman was captured on camera following a customer through a supermarket as she coughs on her after claiming she does not need a mask because she is not sick.  Video of the incident, which has garnered hundreds of thousands of views on Twitter alone, allegedly took place in a Su per Saver in Lincoln, Nebraska according to Twitter user @davenewworld_2. In it, an unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of the customer recording her. Scroll down for video An unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of a woman recording her A woman was captured on camera following a customer as she coughs on her in a supermarket without a mask on claiming she does not need one because she is not sick @chaiteabugz #karen #covid #karens #karensgonewild #karensalert #masks we were just wearing a mask at the store. ¿ o